Skip to main content
. 2020 Jun 13;11:152. doi: 10.25259/SNI_259_2020

Figure 1:

Figure 1:

Sagittal (a) and axial (b) T1-weighted gadolinium- enhanced, sagittal (c), and axial (d) T2-weighted magnetic resonance imaging sequences showing a C1–C2 intramedullary expansive lesion (10 mm×15 mm), T2-hypointense and T1-hyperintense after gadolinium administration.